• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

    2/22/24 7:55:25 AM ET
    $AGRX
    $BELFB
    $BMR
    $BZFD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $AGRX alert in real time by email

    Shares of NVIDIA Corporation (NASDAQ:NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.

    The company reported revenue of $22.10 billion, beating a Street estimate of $20.62 billion. Revenue in the fourth quarter was up 265% year-over-year. Nvidia reported fourth-quarter non-GAAP earnings per share of $5.16, which came in ahead of a Street consensus estimate of $4.64 according to data from Benzinga Pro.

    NVIDIA shares surged 14.3% to $771.50 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Agile Therapeutics, Inc. (NASDAQ:AGRX) gained 140.4% to $2.38 in pre-market trading. Agile Therapeutics was granted extension by Nasdaq Hearings Panel to regain compliance until March 25, 2024. The company sees FY23 revenue of $20 million to $21 million.
    • BuzzFeed, Inc. (NASDAQ:BZFD) shares surged 89.6% to $0.4145 in pre-market trading after the company revealed the sale of Complex Networks to NTWRK, a live-streaming video commerce platform. The deal, valued at $108.6 million, will also result in a 16% reduction in BuzzFeed’s workforce.
    • Elevai Labs, Inc. (NASDAQ:ELAB) shares rose 57.4% to $1.21 in pre-market trading. Braeden Lichti reported a 22.07% stake in Elevai Labs.
    • GRI Bio, Inc. (NASDAQ:GRI) shares jumped 55% to $1.50 in pre-market trading. GRI Bio recently announced pricing of a $5.5 million public offering.
    • Eastside Distilling, Inc. (NASDAQ:EAST) shares rose 38% to $1.32 in pre-market trading.
    • Root, Inc. (NASDAQ:ROOT) shares gained 24.4% to $10.78 in pre-market trading after posting better-than-expected fourth-quarter results.
    • Beamr Imaging Ltd. (NASDAQ:BMR) gained 21.7% to $12.34 in pre-market trading after dipping 18% on Wednesday.
    • Remitly Global, Inc. (NASDAQ:RELY) shares rose 21% to $21.40 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
    • Indivior PLC (NASDAQ:INDV) gained 16.7% to $20.43 in pre-market trading following fourth-quarter results.

    Losers

    • Draganfly Inc. (NASDAQ:DPRO) fell 50.8% to $0.1770 in pre-market trading after the company announced pricing of $3.6 million underwritten public offering.
    • Synaptogenix, Inc. (NASDAQ:SNPX) shares fell 21.2% to $0.2093 in pre-market trading after surging 29% on Wednesday. Synaptogenix received a Notice of Allowance for its U.S. Patent application 17/665,033 titled "Halogenated Esters of Cyclopropanated Unsaturated Fatty Acids for Use in the Treatment of Neurodegenerative Diseases."
    • Bel Fuse Inc. (NASDAQ:BELFB) dipped 20.1% to $55.99 in pre-market trading after posting weaker-than-expected quarterly results.
    • Greenbrook TMS Inc. (NASDAQ:GBNH) shares fell 18.7% to $0.3110 after jumping 94% on Wednesday.
    • Momentus Inc. (NASDAQ:MNTS) shares dipped 18.3% to $0.5636 in pre-market trading after declining around 7% on Wednesday.
    • Visionary Holdings Inc. (NASDAQ:GV) shares fell 15% to $0.17 in pre-market trading.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) fell 14.2% to $13.20 in pre-market trading after the company reported a wider-than-expected loss for its fourth quarter and announced plans to reduce its salaried workforce by around 10% to help further improve costs. The company said it sees production of 57,000 vehicles in 2024.
    • Energy Focus, Inc. (NASDAQ:EFOI) fell 12.7% to $2.00 in pre-market trading after gaining around 66% on Wednesday.
    • Etsy, Inc. (NASDAQ:ETSY) fell 11.3% to $68.44 in pre-market trading after the company reported mixed fourth-quarter financial results.
    • Lucid Group, Inc. (NASDAQ:LCID) shares fell 8.2% to $3.40 in pre-market trading after the company reported mixed fourth-quarter financial results and issued guidance.

     

    Now Read This: NVIDIA, Keurig Dr Pepper And 3 Stocks To Watch Heading Into Thursday

    Get the next $AGRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRX
    $BELFB
    $BMR
    $BZFD

    CompanyDatePrice TargetRatingAnalyst
    Etsy Inc.
    $ETSY
    2/20/2026$72.00Equal Weight → Overweight
    Barclays
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    Remitly Global Inc.
    $RELY
    2/10/2026$18.00Buy
    BofA Securities
    Remitly Global Inc.
    $RELY
    1/27/2026$17.00Overweight
    Cantor Fitzgerald
    NVIDIA Corporation
    $NVDA
    1/15/2026$240.00Outperform
    RBC Capital Mkts
    Rivian Automotive Inc.
    $RIVN
    1/14/2026$15.00Neutral → Sell
    UBS
    More analyst ratings

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Etsy upgraded by Barclays with a new price target

    Barclays upgraded Etsy from Equal Weight to Overweight and set a new price target of $72.00

    2/20/26 8:19:45 AM ET
    $ETSY
    Real Estate

    Rivian Automotive downgraded by DA Davidson with a new price target

    DA Davidson downgraded Rivian Automotive from Neutral to Underperform and set a new price target of $14.00

    2/17/26 7:28:03 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Rivian Automotive upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Rivian Automotive from Hold to Buy and set a new price target of $23.00

    2/13/26 10:14:02 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $AGRX
    $BELFB
    $BMR
    $BZFD
    SEC Filings

    View All

    SEC Form 6-K filed by Draganfly Inc.

    6-K - Draganfly Inc. (0001786286) (Filer)

    3/2/26 8:00:26 AM ET
    $DPRO
    Aerospace
    Industrials

    SEC Form SUPPL filed by Draganfly Inc.

    SUPPL - Draganfly Inc. (0001786286) (Filer)

    2/27/26 8:13:33 AM ET
    $DPRO
    Aerospace
    Industrials

    SEC Form SUPPL filed by Draganfly Inc.

    SUPPL - Draganfly Inc. (0001786286) (Filer)

    2/27/26 8:09:01 AM ET
    $DPRO
    Aerospace
    Industrials

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ryan Barbara bought $27,429 worth of Ordinary Shares (775 units at $35.39), increasing direct ownership by 65% to 1,963 units (SEC Form 4)

    4 - INDIVIOR PLC (0001625297) (Issuer)

    1/7/26 1:51:48 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Humphreys Keith bought $27,429 worth of Ordinary Shares (775 units at $35.39), increasing direct ownership by 15% to 5,802 units (SEC Form 4)

    4 - INDIVIOR PLC (0001625297) (Issuer)

    1/7/26 1:50:38 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ninivaggi Daniel A bought $27,429 worth of Ordinary Shares (775 units at $35.39), increasing direct ownership by 5% to 16,923 units (SEC Form 4)

    4 - INDIVIOR PLC (0001625297) (Issuer)

    1/7/26 1:49:33 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rolle Janet L converted options into 34,924 shares, increasing direct ownership by 29% to 157,034 units (SEC Form 4)

    4 - BuzzFeed, Inc. (0001828972) (Issuer)

    3/2/26 6:05:41 PM ET
    $BZFD
    Telecommunications Equipment
    Consumer Discretionary

    Director Coleman Gregory converted options into 34,924 shares, increasing direct ownership by 9% to 410,608 units (SEC Form 4)

    4 - BuzzFeed, Inc. (0001828972) (Issuer)

    3/2/26 6:05:36 PM ET
    $BZFD
    Telecommunications Equipment
    Consumer Discretionary

    Director Rothstein Adam converted options into 48,894 shares, increasing direct ownership by 6% to 889,932 units (SEC Form 4)

    4 - BuzzFeed, Inc. (0001828972) (Issuer)

    3/2/26 6:05:30 PM ET
    $BZFD
    Telecommunications Equipment
    Consumer Discretionary

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

    HONG KONG, March 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ:GV) ("the Company"), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited ("GV Hong Kong"), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---President Super Injection, in cooperation with Huajin China Investment Company("Huajin China"), alongside the Board-approved divestiture of its non-core education business. These strategic actions mark the Company's formal transition into a commercializati

    3/2/26 9:30:00 AM ET
    $GV
    Other Consumer Services
    Real Estate

    NVIDIA Announces Strategic Partnership With Lumentum to Develop State-of-the-Art Optics Technology

    SANTA CLARA, Calif. and SAN JOSE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- NVIDIA today announced multiyear strategic agreements with Lumentum Holdings Inc. (NASDAQ:LITE) to accelerate innovation in advanced optics technologies, including research and development, to enable next-generation AI infrastructure and systems designs. The nonexclusive agreement includes an NVIDIA multibillion purchase commitment and future capacity access rights for advanced laser components. In addition, NVIDIA is investing $2 billion in Lumentum to support R&D, future capacity and operations as the company builds out its U.S.-based manufacturing capabilities in a new fab. Optical interconnect technology and

    3/2/26 8:00:00 AM ET
    $LITE
    $NVDA
    Telecommunications Equipment
    Telecommunications
    Semiconductors
    Technology

    NVIDIA and Coherent Announce Strategic Partnership to Develop Optics Technology to Scale Next-Generation Data Center Architecture

    SANTA CLARA, Calif. and SAXONBURG, Pa., March 02, 2026 (GLOBE NEWSWIRE) -- NVIDIA and Coherent Corp. (NYSE:COHR) today announced a multiyear strategic agreement to advance the frontier of advanced optics technologies, including manufacturing capacity and research and development, to enable next-generation AI infrastructure. The nonexclusive agreement includes an NVIDIA multibillion-dollar purchase commitment and future access and capacity rights for advanced laser and optical networking products. In addition, NVIDIA is investing $2 billion in Coherent to support research and development, future capacity and operations as Coherent builds out its U.S.-based manufacturing capabilities. Opti

    3/2/26 8:00:00 AM ET
    $COHR
    $NVDA
    Electronic Components
    Technology
    Semiconductors

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Leadership Updates

    Live Leadership Updates

    View All

    Draganfly Welcomes Lieutenant-General (Ret'd) Michel Gauthier to Military Advisory Board in Support of Canada's Defence Industrial Strategy

    Ottawa, ON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning developer of drone solutions, software, and robotics, today announced the appointment of Lieutenant-General (Ret'd) Michel Gauthier to its Military Advisory Board. The appointment comes as Canada advances its renewed Defence Industrial Strategy, a national framework focused on strengthening sovereign defence production, accelerating innovation, modernizing procurement, and reducing reliance on foreign supply chains. Lieutenant-General Gauthier brings more than 36 years of distinguished service with the Canadian Armed Forces. He served as Comman

    2/20/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer

    SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company") today announced the appointment of Sebastian J. Gunningham as Chief Executive Officer ("CEO") and member of the Board of Directors (the "Board"), effective February 19, 2026. Mr. Gunningham succeeds Co-Founder Matt Oppenheimer, who decided to transition the role of CEO to a new leader after nearly 15 years of driving transformative growth that built Remitly into one of the world's leading networks for digital and physical money movement. Mr. Oppenheimer will continue to serve as Chairman of the Board. Sebastian Gunningham brings decades of global leadership and product innovation exp

    2/18/26 4:05:00 PM ET
    $RELY
    Real Estate

    Remitly Reports Fourth Quarter and Full Year 2025 Results Above Outlook

    Reported first full year of GAAP profitabilityRecord fourth quarter results: revenue of $442.2 million, net income of $41.2 million, and Adjusted EBITDA of $88.6 million SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY), a trusted provider of financial services that transcend borders, reported results for the fourth quarter and full year ended December 31, 2025. "We ended 2025 with very strong results, exceeding our guidance for both revenue and Adjusted EBITDA," said Matt Oppenheimer, co-founder and Chief Executive Officer, Remitly. "These exceptional results and the strategic accomplishments realized in 2025 create the right moment to accelerate execution wi

    2/18/26 4:04:00 PM ET
    $RELY
    Real Estate

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Financials

    Live finance-specific insights

    View All

    Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results

    Generated Record Quarterly and Full-Year Total SUBLOCADE® Net Revenue of $252 Million and $856 MillionAchieved Quarterly and Full-Year GAAP Net Income of $102 Million and $210 Million; Non-GAAP Quarterly and Full-Year Net Income of $107 Million and $320 MillionDelivered Record Quarterly and Full-Year Adjusted EBITDA of $142 Million and $428 MillionEntered Phase II of the Indivior Action Agenda – Accelerate – on January 1, 2026Authorized New $400 Million Share Repurchase ProgramReaffirmed Full-Year 2026 Financial Guidance Announced on January 8, 2026Conference Call at 8:00 A.M. EST Today RICHMOND, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today

    2/26/26 7:00:00 AM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    Root, Inc. Announces 2025 Fourth Quarter and Full Year Results

    COLUMBUS, Ohio, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ:ROOT), today announced financial results for the fourth quarter and full year ended December 31, 2025. Root's fourth quarter and full year financial results and management commentary can be found in the shareholder letter posted to the company's investor relations website. An updated version of the company's investor presentation will also be available. Both can be found on ir.joinroot.com. Root will host a conference call and earnings webcast to discuss the results and provide an update on company operations today, Wednesday, February 25, 2026 at 5:00 p.m. Eastern Time. To listen to the live audio webcast, please visit

    2/25/26 4:15:00 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    $AGRX
    $BELFB
    $BMR
    $BZFD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Indivior PLC

    SC 13G - INDIVIOR PLC (0001625297) (Subject)

    11/15/24 6:03:54 PM ET
    $INDV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Bel Fuse Inc.

    SC 13D/A - BEL FUSE INC /NJ (0000729580) (Subject)

    11/15/24 4:10:18 PM ET
    $BELFB

    SEC Form SC 13G filed by Elevai Labs Inc.

    SC 13G - Elevai Labs Inc. (0001840563) (Subject)

    11/14/24 5:53:26 PM ET
    $ELAB
    Biotechnology: Pharmaceutical Preparations
    Health Care